Covered recipient · General Payments record
LOUIS BAIRD KASUNIC
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$5,783.73
- Reported across 284 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $279.35 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $63.64 | 4 |
| PFIZER INC. | $54.59 | 2 |
| Novo Nordisk AS | $35.65 | 2 |
| Acerta Pharma LLC | $24.13 | 1 |
| Exact Sciences Corporation | $24.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.83 | 1 |
| GlaxoSmithKline, LLC. | $14.62 | 1 |
| Lilly USA, LLC | $14.02 | 1 |
| Medicure Pharma Inc. | $12.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.91 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997610685 | CMS |
| ABBVIE INC. | $20.21 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997610687 | CMS |
| ABBVIE INC. | $17.65 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997610689 | CMS |
| ABBVIE INC. | $12.87 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997610691 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.13 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014296535 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.83 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000112185 | CMS |
| Exact Sciences Corporation | $24.00 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026545343 | CMS |
| GlaxoSmithKline, LLC. | $14.62 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003516129 | CMS |
| Lilly USA, LLC | $14.02 | 03/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031832859 | CMS |
| Medicure Pharma Inc. | $12.83 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993539703 | CMS |
| Novartis Pharmaceuticals Corporation | $18.04 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992103095 | CMS |
| Novo Nordisk Inc | $18.36 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000199897 | CMS |
| Novo Nordisk Inc | $17.29 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000199889 | CMS |
| PFIZER INC. | $25.35 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050674173 | CMS |
| PFIZER INC. | $29.24 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049443719 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.